Clinical and pharmacokinetic study of gemcitabine (GEM) - oxaliplatin (OXA) association in metastatic or locally advanced pancreatic adenocarcinoma
Mario Airoldi, Carlo Zanon(The Netherlands Cancer Institute), Luigi Cattel(University of Turin), E. Ferrarato(Ospedale San Giovanni Antica Sede), C. Micari(University of Turin), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 1
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k